Chitosan–Type-A-Gelatin Hydrogels Used as Potential Platforms in Tissue Engineering for Drug Delivery

Hanaa Mehdi-Sefiani,Carmen Mª Granados-Carrera,Alberto Romero,Ernesto Chicardi,Juan Domínguez-Robles,Víctor Manuel Perez-Puyana

DOI: https://doi.org/10.3390/gels10070419

IF: 4.6

2024-06-27

Gels

Abstract:Hydrogels are materials made of crosslinked 3D networks of hydrophilic polymer chains that can absorb and retain significant amounts of water due to their hydrophilic structure without being dissolved. In relation to alternative biomaterials, hydrogels offer increased biocompatibility and biodegradability, giving them distinct advantages. Thus, hydrogel platforms are considered to have the potential for the development of biomedical applications. In this study, the main objective was the development of hybrid hydrogels to act as a drug delivery platform. These hydrogels were made from chitosan (CH) and type A gelatin (G), two natural polymers that provide a supportive environment for cellular attachment, viability, and growth, thanks to their unique properties. Particularly, the use of gelatins for drug delivery systems provides biodegradability, biocompatibility, and non-toxicity, which are excellent properties to be used in the human body. However, gelatins have some limitations, such as thermal instability and poor mechanical properties. In order to improve those properties, the aim of this work was the development and characterization of hybrid hydrogels with different ratios of CH–G (100–0, 75–25, 50–50, 25–75, 0–100). Hydrogels were characterized through multiple techniques, including Fourier transform infrared (FTIR) spectroscopy, rheological and microstructural studies, among others. Moreover, a model hydrophilic drug molecule (tetracycline) was incorporated to evaluate the feasibility of this platform to sustain the release of hydrophilic drugs, by being tested in a solution of Phosphate Buffer Solution at a pH of 7.2 and at 37 °C. The results revealed that the synergy between chitosan and type A gelatin improved the mechanical properties as well as the thermal stability of it, revealing that the best ratios of the biopolymers are 50–50 CH–G and 75–25 CH–G. Thereby, these systems were evaluated in a controlled release of tetracycline, showing a controlled drug delivery of 6 h and highlighting their promising application as a platform for controlled drug release.

polymer science

What problem does this paper attempt to address?

The paper aims to address the limitations present in drug delivery systems (DDS), such as low bioavailability, fluctuations in drug concentration in plasma, limited drug solubility, poor tissue distribution, and uncontrollable drug release characteristics. Specifically, the main objective of the study is to develop hybrid hydrogels based on chitosan (CH) and type A gelatin (G) as drug delivery platforms and to evaluate the potential applications of these hydrogels in tissue engineering.

The study involves the preparation of hybrid hydrogels with different ratios (100–0, 75–25, 50–50, 25–75, 0–100) of chitosan and type A gelatin, and their characterization using various techniques (such as Fourier-transform infrared spectroscopy, rheology, and microstructure analysis). Additionally, tetracycline is incorporated as a model water-soluble drug molecule into the hydrogels to assess the feasibility of this platform for sustained release of water-soluble drugs. The experimental results indicate that the synergistic interaction between chitosan and type A gelatin improves the mechanical properties and thermal stability of the hydrogels, with the 50–50 and 75–25 ratios of biopolymer combinations exhibiting the best performance. The controlled release experiments of tetracycline in these systems demonstrated a sustained drug release effect for 6 hours, highlighting their potential as controlled release drug platforms.